FDA Approved: LOCAMETZ — Supplemental Application (Advanced Accelerator Applications USA, Inc)

View source ↗

Summary

FDA approved a supplemental application for LOCAMETZ to include a kit for the preparation of Gallium-68 gozetotide for PET imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• LOCAMETZ (kit for the preparation of gallium-68 gozetotide)

Snippet

SUPPL AP for LOCAMETZ (KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE)